Press "Enter" to skip to content

New tentative approval for Gilead Sciences drug sofosbuvir

0
Copyright © DrugPatentWatch. Originally published at New tentative approval for Gilead Sciences drug sofosbuvir [![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog)
Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound.

Drug patent litigation for SOFOSBUVIR.

One supplier is listed for this compound. There is one tentative approval for this compound.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New tentative approval for Gilead Sciences drug sofosbuvir
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!